r Paramyotonia congenita is a hereditary channelopathy caused by missense mutations in the SCN4A gene, which encodes the α subunit of the human skeletal muscle voltage-gated sodium channel NaV1.4.
r Affected individuals suffered from myotonia and paralysis of muscles, which were aggravated by exposure to cold.
r We report a three-generation Chinese family with patients presenting paramyotonia congenita and identify a novel N1366S mutation of NaV1.4.
r Whole-cell electrophysiological recordings of the N1366S channel reveal a gain-of-function change of gating in response to cold. Modelling and molecular dynamic simulation data suggest that an arginine-to-serine substitution at position 1366 increases the distance from N1366 to R1454 and disrupts the hydrogen bond formed between them at low temperature.
r We demonstrate that N1366S is a disease-causing mutation and that the temperature-sensitive alteration of N1366S channel activity may be responsible for the pronounced paramyotonia congenita symptoms of these patients.
Abstract Paramyotonia congenita is an autosomal dominant skeletal muscle channelopathy caused by missense mutations in SCN4A, the gene encoding the α subunit of the human skeletal muscle voltage-gated sodium channel NaV1.4. We report a three-generation family in which six members present clinical symptoms of paramyotonia congenita characterized by a marked worsening of myotonia by cold and by the presence of clear episodes of paralysis. We identified a novel mutation in SCN4A (Asn1366Ser, N1366S) in all patients in the family but not in healthy relatives or in 500 normal control subjects. Functional analysis of the channel protein expressed in HEK293 cells by whole-cell patch clamp recording revealed that the N1366S mutation led to significant alterations in the gating process of the NaV1.4 channel. The N1366S mutant displayed a cold-induced hyperpolarizing shift in the voltage dependence of activation and a depolarizing shift in fast inactivation, as well as a reduced rate of fast inactivation and accelerated recovery from fast inactivation. In addition, homology modelling and molecular dynamic simulation of N1366S and wild-type NaV1.4 channels indicated that the arginine-to-serine substitution disrupted the hydrogen bond formed between N1366 and R1454. Together, our results suggest that N1366S is a gain-of-function mutation of NaV1.4 at low temperature and the mutation may be responsible
Introduction
Human skeletal muscle voltage-gated sodium channel NaV1.4 is essential for the generation and propagation of the muscle action potentials that initiate muscle contraction (Cannon, 2015; Nicolea & Fontainea, 2015) . Dysfunctions of the NaV1.4 channel result in autosomal dominant skeletal muscle disorders, including paramyotonia congenita (PMC), sodium channel myotonia (also known as potassium aggravated myotonia), hypokalemic periodic paralysis, hyperkalemic periodic paralysis and congenital myasthenic syndrome (Jurkat-Rott et al. 2010) . Among these, PMC is characterized by paradoxical myotonia that is aggravated by repetitive activity, as well as by the presence of episodes of muscle weakness (Lehmann-Horn et al. 1993; Platt & Griggs, 2009) . PMC is also distinguished because it can be induced by cold temperatures (Matthews et al. 2010; Egri & Ruben, 2012) .
The NaV1.4 channel consists of a pore-forming α subunit and a regulatory β subunit. The α subunit, which is encoded by the SCN4A gene, comprises four homologous domains (D1-D4) and each domain contains six transmembrane segments (S1-S6) (Catterall, 2001) . Gating of the NaV1.4 channel is conferred by conformational changes in response to membrane depolarization and, within milliseconds following depolarization, the channel enters a non-conducting 'fast' inactivation state, whereas, with prolonged depolarization, the channel enters a 'slow' inactivated state (Goldin, 2003; Ulbricht, 2005; Catterall, 2012) . Defective gating transitions of mutant NaV1.4 channels have been suggested to be responsible for the PMC phenotype . For example, Q270K and P1158S mutants are defective in slow inactivation, whereas mutant T1313A and F1473S show impaired fast inactivation (Fleischhauer et al. 1998; Bouhours et al. 2004; Webb & Cannon, 2008; Carle et al. 2009 ). Enhancement of NaV1.4 channel activation has been reported for the mutants P1158S and R1448H (Chahine et al. 1994; Mohammadi et al. 2003; Sugiura et al. 2003) . Although PMC is featured pathologically by a marked worsening of the symptom with cold, diverse responses to temperature have been reported in NaV1.4 mutations. The abnormal temperature sensitivity of slow inactivation but not of fast inactivation has been characterized for the Q270K mutant. Explicitly, patients with a proline, cysteine or histidine substitution at R1488 show different degrees of clinical severity of the disease, and a more severe PMC phenotype occurs with R1448P, a less temperature-sensitive mutant (Lerche et al. 1996) . Therefore, new PMC mutations are yet to be identified with respect to investigating the precise functional abnormalities conferred on the NaV1.4 channel and the temperature sensitivity relationship to defective channel behaviours.
In the present study, we report the identification of a novel SCN4A N1366S mutation in six PMC patients presenting with cold-sensitive myotonia and paralysis. Electrophysiological analysis and molecular simulation demonstrated that an asparagine-to-serine substitution at 1366 led to temperature-sensitive defects of the NaV1.4 channel and may account for the clinical symptoms of PMC patients in the affected family.
Methods

Ethical approval
The present study complied with the Declaration of Helsinki and the policy of The Journal of Physiology (Grundy, 2015) , except for registration in a database. The study was performed in strict accordance with the institutional guidelines of Zhejiang University, China. All procedures were approved by the Ethics Committee of the First Affiliated Hospital of the School of Medicine, Zhejiang University (institutional reference number: 2015-444). Informed consent was given by all patients for the use of blood samples.
recorded from the abductor digiti minimi (ADM) muscle with surface electrodes taped in place using a belly-tendon configuration. In the short exercise test (SET), CMAPs were recorded from the left ADM at room temperature (skin temperature maintained at 33°C) and from the right ADM at a cold temperature (skin temperature maintained at 20°C). The skin was cooled using ice packs and the temperature was measured by a non-contact electronic thermometer. CMAPs were recorded immediately after a 10-s isometric contraction, and then every 10 s for a total of 1 min. The SET was repeated three times at 1-min intervals. The long exercise test (LET) was performed using the left ADM with the skin temperature maintained at 33°C, and CMAPs were recorded immediately after a long exercise lasting 5 min, and then every 5 min for 55 min.
Molecular genetic analysis
Genomic DNA was extracted from blood samples using a DNA purification kit (Sigma, St Louis, MO, USA). All exons of the SCN4A gene were amplified using primers and PCR protocols described previously (Miller et al. 2004) and were sequenced on an ABI PRISM 377 (Perkin Elmer, Waltham, MA, USA).
Plasmid constructs
The cDNA of human NaV1.4 was purchased from Vigene Bioscience. pRc-CMV NaV1.4 and human NaV β1 subunit in the GW vector were generously provided by Dr Cannon. The N1366S (c4097A>G) mutation was introduced and subcloned into the pRc-CMV vector using an In-Fusion HD Cloning Kit (Clontech, Palo Alto, CA, USA). An NheI-XhoI fragment of the wild-type (WT) NaV β1 subunit was subcloned into the pIRES2-EGFP vector. All sequences were confirmed by sequencing both strands.
Cell culture and transfection
HEK293 cells were obtained from ATCC and maintained at 37°C with 5% CO 2 in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum (Gibco, Gaithersburg, MD, USA). The plasmids expressing the NaV1.4 α and β1 subunits were co-transfected at a ratio of 1:1 into HEK293 cells using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA). Transfection-positive cells were identified by use of green fluorescent protein and were used for whole-cell patch clamp recording.
Electrophysiological recording
Conventional whole-cell patch clamp recording was used to examine the voltage-gated Na + currents (Sakmann & Neher, 1984) . All of the data were collected using an Axopatch 200B, Digidata1440A (Axon Instruments, Foster City, CA, USA) with a low-pass Bessel-filter at 10 kHz and digitally sampled at 50 kHz. The pipette solution contained 10 mM NaF, 110 mM CsF, 20 mM CsCl, 2 mM EGTA and 10 mM Hepes (pH 7.35, 310 mOsm kg −1 ). The bath solution contained 145 mM NaCl, 4 mM KCl, 1.8 mM CaCl 2 , 1 mM MgCl 2 , 10 mM D-(+)-glucose and 10 mM Hepes (pH 7.35, 310 mOsm kg −1 ). Recordings were performed in a temperature-controlled chamber. To minimize voltage errors, we focused on data from cells expressing maximal peak Na + current amplitudes between 1 and 8 nA. By using low resistance pipettes and 80-90% series resistance compensation (Herzog et al. 2003) , the average series resistance in these cells was 1.9 ± 0.2 M and the estimated maximum voltage error of the recordings was 2.0 ± 0.4 mV.
Homology modelling and molecular dynamic simulations
The homology models of human WT NaV1.4 and the N1366S mutant were created based on the crystal structures of a eukaryotic sodium channel from the American cockroach (NaVPaS, Protein Data Bank code: 5 × 0 M) using MODELLER, version 9.9 (Sali & Blundell, 1993; Zhao et al. 2014; Shen et al. 2017) . The constructed models were checked and validated by ProCheck (Laskowski et al. 1993) . Molecular dynamic (MD) simulations were performed using the DESMOND, version 3.0, with a constant number of particles, pressure (1 bar), temperature (283 K, 10°C) and periodic boundary conditions (buffer distance of 10Å to each dimension of the simulation box) (Shaw, 2005) . A particular 'neutral territory' method (midpoint method) was employed to efficiently exploit a high degree of computational parallelism. A default OPLS 2005 force field, following the functional form of the OPLS-AA family of force fields, was used for the NaV1.4 protein. The energy-minimized structures determined by DESMOND, version 3.0, were used as the starting structures for MD simulations. A large dimyristoylphosphatidylcholine bilayer was constructed to generate a suitable membrane system in which the transmembrane domain of NaV1.4 could be embedded. The protein/dimyristoylphosphatidylcholine system was subsequently dissolved in simple point charge water molecules and counter ions were then added to compensate for the net negative charge of the system. NaCl (150 mM) was added into the simulation box that represented background salt under physiological conditions. All of the MD simulations were run on a TC2600 system (Dawning, Tianjin, China). Preparation analysis, and visualization were performed on a T7500 graphics workstation (Dell Inc., Round Rock, TX, USA). 
Results
Patient evaluations
The three-generation pedigree presented in Fig. 1A shows two female and four male patients from a Chinese family with a history of cold-sensitive myotonia plus paralysis. The proband (patient III: 9) is a 28-year-old man who suffered muscle stiffness starting early in childhood. The phenotype worsened with prolonged exercise or after cold exposure to affect the eyelids, jaw, face, hands and legs. In addition to muscle stiffness, the proband also suffered from episodic muscle weakness, which usually occurred in the morning when he awoke. During the episodes, he referred to stiffness and pain in both legs and difficulty in climbing stairs but had normal breathing and swallowing. Episodic weakness occurred three to five times per year, and this symptom usually lasted 3-15 days and then recovered spontaneously. An attack of paralysis accompanied by muscle stiffness and cold could trigger and exacerbate the weakness. Clinical examination between attacks of paralysis indicated grasp or percussion myotonia. Muscle strength according to the Medical Research Council Rating Scale, as well as thyroid function, blood biochemistry (including potassium levels) between attacks and blood potassium levels during attacks, were normal. Foods rich in potassium did not induce the symptoms and the patient was unresponsive to potassium supplements. These disease phenotypes implied an association with PMC disorders. Other patients in this family also experienced cold-sensitive myotonia and paralysis (Table 1) . To further characterize the muscle disorders of the patients, an EMG examination was performed. Needle EMG results indicated frequent spontaneous discharges in the patients but not in 20 healthy subjects (Fig. 1B) . The SET and LET were performed to further evaluate the physiological responses of muscles in the patients. At 33°C (skin temperature), repeated short exercise (10 s, three times) resulted in a 16% decrease in the CMAP amplitude in patients ( Fig. 1E and F) . A post-exercise myotonic potential (PEMP) was present only in the first recordings after exercise completion and did not reappear with repetitive stimulation. With cooling to 20°C, a dramatic decline of 35% in the CMAP was found immediately after the first exercise and this decreased further to 73% after the third trial. Note that neither a PEMP, nor a significant decrease of the CMAP was detected in the SET in control subjects ( Fig. 1C and D) . Moreover, in the LET performed at 33°C, the CMAP amplitude gradually decreased to 55% within 55 min, implying a severe and persistent impairment of muscle excitability (Fig. 1G ). The typical pattern I profile of the EMG presented by the proband is most frequently reported in PMC patients (Fournier et al. 2004 (Fournier et al. , 2006 . The manifestations of myotonia and PEMPs, as well as a decreased post-exercise CMAP amplitude that worsened with repetitive or prolonged exercise, were consistent with clinical observations, suggestive of a diagnosis of PMC.
EMG can be used to distinguish PMC from other types of muscle disorder and genomic sequencing of the SCN4A gene serves as the definitive diagnostic determinant. Sequence analysis of affected members identified a c.4097A>G exchange in exon 23 of the SCN4A gene, which resulted in the substitution of asparagine for serine at codon 1366 (Asn1366Ser, N1366S) in D4/S1 of the NaV1.4α subunit ( Fig. 2A and B) . The N1366S mutation was found in all patients in the family but not in healthy relatives or in 500 normal control subjects. Alignment of the amino acid sequences flanking Asn1366 across all nine known human sodium channels (NaV1.1 to NaV1.9) revealed that Asn1366 is a highly conserved residue (Fig. 2C ). This conservation was also found across multiple species (vertebrates and bacteria) ( Fig. 2D and E) .
Cold-induced enhancement of N1366S NaV1.4 channel activation
To determine the functional impact of the N1366S mutation on the NaV1.4 channel, we performed whole-cell patch clamp recordings from WT or mutated NaV1.4 channels ectopically expressed in HEK293 cells. Because the patients with N1366S mutations were clinically characterized by a marked worsening of muscle stiffness and weakness in the cold, we compared the voltage-gated Na + currents between 20°C and 30°C to assess the effects of temperature. At 30°C, no significant difference between 
Muscle disorder of PMC patients
A, pedigree with proband (arrow) and other affected family members shown as solid symbols (square, male; circle, female; subjects examined are indicated by an asterisk). B, representative needle EMG recording for control subject and proband. C, representative CMAP recordings from control subject at room temperature. Top trace, pre-exercise recording. Subsequent traces, post-exercise recordings at different times after completion of 10-s muscle exercise (Ex.). D, amplitude of CMAPs in the short exercise test at room temperature ( ) or at a cold temperature ( ) in a control subject. E, representative CMAP recordings from the proband at room temperature. Top trace, pre-excise recording. Subsequent traces, post-exercise recordings at different times after completion of 10-s muscle exercise (Ex.). PEMP is indicated by arrow. F, amplitude of CMAPs in the short exercise test at room temperature ( ) or at a cold temperature ( ) in the proband. G, CMAP amplitude in the long exercise test in the proband at room temperature. CMAP amplitude is plotted as a percentage of the pre-exercise value.
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WT and N1366S mutant was found in channel activation (Fig. 3A-D and Table 2 ). However, upon cooling to 20°C, the Na + currents of HEK293 cells expressing the N1366S mutant reached a maximum at a voltage of −10 mV, in marked contrast to that of the WT (0 mV). The half-maximal activation potential (V 0.5 ) of the N1366S mutant was −31.3 ± 0.2 mV, which corresponds to a hyperpolarizing shift of ß10 mV compared to the WT (V 0.5 = −21.7 ± 0.2 mV, n = 15) (Fig. 3E-G) . In addition, the voltage dependence of the activation curve of N1366S displayed a steeper pattern than that of the WT at 20°C, showing a significantly decreased slope factor (k = 4.3 ± 0.2 mV, n = 12) relative to the WT (k = 5.5 ± 0.2 mV, n = 15) (Fig. 3H) . Notably, upon cooling the bath from 30°C to 20°C, the V 0.5 of the N1366S mutant shifted from −26.5 ± 0.4 mV to −31.3 ± 0.2 mV in a hyperpolarized direction, opposite to the depolarizing shift for WT NaV1.4 channels (−25.7 ± 0.5 mV to −21.7 ± 0.2 mV) ( Table 2) .
Cold-induced defects in fast inactivation of N1366S NaV1.4 channel The V 0.5 and the slope factor of the fast inactivation curve, as well as the fast inactivation time constant (τ h ) of the The intracellular loop connecting D3/S6 and D4/S1 contains the isoleucine, phenylalanine and methionine (IFM) domain involved in channel inactivation. N1366S is shown as a red dot in D4/S1. C-E, protein alignment showing that the affected residue N1366 (highlighted in black) is conserved cross in all human NaV channels (C) and in vertebrate orthologs (D), as well as in bacterial NaV channels (E).
N1366S mutant and WT, were comparable at 30°C (Fig. 4A and B and Table 2 ). For example, the τ h at −10 mV for N1366S (0.28 ± 0.03 ms, n = 14) was similar to that of the WT (0.25 ± 0.02 ms, n = 14). However, cooling to 20°C led to a ß6 mV depolarizing shift of V 0.5 in the N1366S mutant (−62.5 ± 0.4 mV, n = 14) as compared to the WT (−68.1 ± 0.7 mV, n = 14) (Fig. 4D) . Decreasing the temperature from 30°C to 20°C also caused a greater slope factor of the fast inactivation curve of the N1366S mutant (7.4 ± 0.4 mV, n = 14) than the WT (5.3 ± 0.6 mV, n = 14). Moreover, τ h at 20°C for N1366S was greater than that for WT (at −10 mV, 0.46 ± 0.04 ms for N1366S and 0.33 ± 0.02 ms for WT) (Fig. 4E) . These results suggest a slow rate of entry into fast inactivation for N1366S. On the other hand, the recovery time constant (τ 1 ) of the N1366S mutant (0.43 ± 0.2 ms, n = 14) was smaller than that of the WT (0.66 ± 0.05 ms, n = 14) at 20°C but not at 30°C ( Fig. 4C and F) , implying an accelerated recovery from fast inactivation at lower temperature for the N1366S mutant. The window current indicated by steady-state fast inactivation and activation diagrams (Fig. 5) revealed that the region of overlap between the inactivation and activation curves of N1366S was similar to that of WT at 30°C. The cold-induced shift of the curves resulted in an wider overlap in the N1366S channel, indicating an increased window current at lower temperature. Although significant differences were found between the N1366S mutant and the WT in the activation and fast inactivation upon channel gating, the N1366S mutant in the voltage dependence of steady-state slow inactivation and in the kinetics of entry into or recovery from slow inactivation was almost identical to the WT at either 30°C or 20°C (Fig. 6 and Table 2 ). These results indicate that the slow inactivation may not be the decisive factor for the clinical phenotype and disease pathogenesis attributed to the N1366S mutant.
Cold-induced disruption of hydrogen bond between N1366S and R1454
The crystal structures of prokaryotic NaV homologues from NaVAb (Arcobacter butzleri) and NaVRh (Rickettsiales sp.) revealed a spatial proximity of N25 (N1366 in NaV1.4) to the S4 segment and the formation of a hydrogen bond between N25 and arginine residues in the S4 segment (Payandeh et al. 2011; Zhang et al. 2012) . The formation of a hydrogen bond between N1366 and R1454 has also been resolved from the recent crystal structure of the eukaryotic sodium channel from the American cockroach (NaVPaS), a channel with ß46% sequence identity to human NaV1.4 (Shen et al. 2017) . Thus, a structurally conserved hydrogen bond probably forms between N1366 and R1454 in the NaV1.4 channel. We therefore constructed a NaV1.4 homology model based on the structure of NaVPaS and performed MD simulations of the WT and the N1366S mutant at a low temperature to determine whether the serine substitution at N1366 would perturb the formation of a hydrogen bond. The simulations of the channels equilibrated in dimyristoylphosphatidylcholine membrane in silico (Fig. 7A) were run for 100 ns at 10°C. During the 100-ns time scale, the root mean square deviation for the backbone atoms of the N1366S mutant was close to that of the WT channel, indicating a global structural similarity between these two proteins (Fig. 7B) . The proximity of the side chains of N1366 (WT) or S1366 (mutant) to that of R1454 was measured by the N-O bond distance (Fig. 7C ). Guanidinium (RNHC(NH2) 2+ ) of N1366 (WT) was found to be in close proximity to the anionic carboxylate (R-COO − ) of R1454, resulting in an N-O bond distance of 3.08 ± 0.46Å. In contrast, the hydroxyl (R-OH) of S1366 (mutant) was distal to the R-COO − of R1454 throughout simulation, represented by an N-O bond distance of 7.83 ± 0.54Å. For example, S1366 was 5.8Å from R1454 at the start of simulation, 7.2Å at 10 ns into simulation, and remained 8.6Å at 60 ns and 8.1Å at 100 ns (Fig. 7E) . These results imply the formation of a hydrogen bond between N1366 and R1454 in the NaV1.4 channel at a cold temperature and further suggest that the asparagine-to-serine substitution at 1366 increases the N-O bond distance between the side chains of S1366 and R1454 and thus leads to disruption of the hydrogen bond.
Discussion
PMC is a hereditary channelopathy caused by missense mutations in the muscle sodium channel gene SCN4A. Affected individuals suffer from myotonia and paralysis of muscles, which can be aggravated by exposure to cold. In the present study, we report on patients with the symptoms of PMC who were suffering cold-sensitive myotonia plus paralysis in a three-generation family. Using exon sequencing, we found a novel N1366S mutation in the SCN4A gene of six patients. Alignment analysis further showed that N1366 is a highly conserved amino acid across human NaV channel proteins and even in evolutionarily distant orthologues. The functional consequences of N1366S examined in a mammalian expression system revealed defects of cold-sensitive responses in mutant channels, thus providing further evidence for a genotype-phenotype correlation in PMC.
Impairments of fast inactivation have been shown to cause persistent hyperexcitability of skeletal muscle, resulting in myotonia. Indeed, PMC mutants such as T1313A and F1473S have been reported to show defects in fast inactivation (Fleischhauer et al. 1998; Bouhours et al. 2004) . Here, we report temperature-dependent impairments of fast inactivation in the N1366S mutant channel. The N1366S mutant displayed a 6-mV depolarizing shift in the voltage dependence of fast inactivation relative to the WT. As a result, a greater The voltage dependence of fast inactivation was assessed by applying a double-pulse protocol: 500-ms pre-pulses were applied from −150 to 0 mV in steps of 10 mV and followed by a test pulse to −10 mV (left middle inset). The steady-state fast inactivation curve was fitted by the Boltzmann equation (I/I max = {1 + exp[(V − V 0.5 )/k]} −1 ). B and E, fast inactivation time constant τ h of WT and N1366S was derived from a monoexponential fit to the current decay of mutant and WT channels. The inset trace shows the current decay of WT and N1366S at −10 mV. C and F, recovery from fast inactivation was assessed by a two-pulse recovery protocol with varying time intervals between a 100-ms inactivating pre-pulse and a test pulse to −10 mV (right middle inset). The time course of recovery from inactivation was fitted with a double-exponential function to generate τ 1 and τ 2 . Data are presented as the mean ± SEM. All fitting data are listed in Table 2 . level of depolarization may be reached for the N1366S channel to enter the fast inactivation state. Thus, with normal depolarization the N1366S channel remained activated when the WT channel was inactive. Moreover, N1366S mutant channels entered fast inactivation more slowly and displayed a more rapid recovery. Together with these cold-induced gain-of-function changes that are predicted to increase the action potential duration and to reduce the refractory period, the pronounced effects of cooling from 30°C to 20°C on the N1366S mutant may act synergistically with the mutation to increase the propensity for myotonia at low temperature. Although defective fast inactivation of NaV1.4 mutants is tightly linked to muscle stiffness in PMC, the channel abnormalities associated with muscle weakness, another typical PMC phenotype, are diverse. Q270K is associated with atypical paramyotonia myotonia characterized by cold-induced paralysis supported by cold-induced disruption of slow inactivation (Carle et al. 2009 ). This mutation does not induce an enhancement but rather a slight impairment of channel activation. P1158S is associated with cold-induced hypokalemic paralysis and myotonia at warm temperatures. This mutation enhances channel activation and disrupts slow inactivation at cold (Sugiura et al. 2003; Webb & Cannon, 2008) . NaV1.4 channel activation at more negative potentials has also been reported for the paralysis-causing mutation T704M (T698M in the rat homologue) (Cummins et al. 1993) . T704M is associated with hyperkalemic periodic paralysis and is not known to be cold-sensitive; it enhances channel 
where A represents the fraction of channels resistant to slow inactivation. B and E, entry into slow inactivation was assessed by applying a double-pulse protocol with pre-pulse times varying from 50 ms to 10 s and a test pulse to −10 mV (middle inset). The time constant τ of entry into inactivation was derived by fitting a single-exponential decay. C and F, recovery from slow inactivation was assessed by a 30-s prepulse followed by altering the recovery time from 30 ms to 10 s prior to a test pulse to −10 mV (right inset). The time constant τ of recovery from slow inactivation was derived by fitting to a single-exponential function. Data are presented as the mean ± SEM. All fitting data are listed in Table 2 .
activation and disrupts slow inactivation (Hayward et al. 1999) . In the N1366S mutant, we detected prominent gain-of-function changes in channel activation with cooling but kinetics comparable to the WT in slow activation. The negative shift in the voltage dependence of activation at low temperature implied that N1366S would have a lower open threshold than the WT, thereby increasing the risk of a persistent Na current, which could lead to stable depolarization of the resting membrane potential. The excessive depolarization caused by the hyperexcitability of the N1366S mutant could subsequently inactivate the channels and, ultimately, lead to loss of excitability and paralysis in a cold environment (Egri & Ruben, 2012) . The increased window current of N1366S at lower temperature may result in an increase of inward Na + current, causing increased excitability and subsequent paralysis.
PMC is known for its sensitivity to temperature. Coldinduced symptoms of either myotonia or paralysis were observed in the patients with N1366S-mutated NaV1.4 channels, as expected. However, in comparison with the WT, cooling resulted in a pronounced depolarizing shift in the fast inactivation of the N1366S mutant channel, as well as altered gating kinetics such as a reduced rate of fast inactivation and an accelerated recovery from fast inactivation. Moreover, the voltage dependence of N1366S channel activation shifted to more negative membrane potentials at a lower temperature. These results suggest that the temperature-sensitive phenotype of PMC is not only dependent on the slowing of channel kinetics at cooler temperatures, but also conferred by subtle temperature-dependent changes in N1366S channel gating.
The temperature-sensitive defects induced by the N1336S mutation on the activation and fast inactivation of the NaV1.4 channel suggest a vital role of Asn1366. Located in D4/S1, N1366 is structurally close to D4/S4, a region that has been proposed to be the voltage-sensing domain (VSD) of the channel. Previous structure-function studies have indicated that the repeated positively charged arginine residues (R1-R4) in the S4 segment undergo outward displacement in response to depolarization to initiate opening of the central pore. The ion-pair interactions of arginines through either negative-charge clustering or additional contacts are expected to stabilize the gating charges and engage in S4 movement in the electrical field of the membrane (Catterall, 2000 (Catterall, , 2010 Chanda et al. 2005) . Interestingly, the crystal structures of two prokaryotic NaV homologues (NaVAb and NaVRh), as well as the eukaryotic sodium channel NaVPaS, revealed a hydrogen bond between N1366 and arginine in S4 (Payandeh et al. 2011; Zhang et al. 2012; Shen et al. 2017) . Given that N1366 is highly conserved from prokaryotes to human (Fig. 2) , we predict that this residue may function by engaging S1-S4 interactions to stabilize gating charges. Asparagine-to-serine substitution at 1366, therefore, may lead to an electrostatic or steric imbalance in the interaction with arginine during channel gating. Recent studies of orthologous bacterial channels based on the disulphide locking of cysteine double mutants (DeCaen et al. 2011; Catterall, 2012) as well as structural modelling (Amaral et al. 2012; Yarov-Yarovoy et al. 2012 ) have indicated state-dependent interactions between residues in S1 and arginines in S4, suggesting that the polar side chain at S1 is involved in a dynamic hydrogenbonding network during the transfer of gating charges through the gating pore. Our MD simulation studies demonstrated that the asparagine-to-serine substitution at position 1366 increases the distance of N1366 from R1454 and disrupts the hydrogen bond formation between them at low temperature. Thus, we hypothesize that the conformational changes of N1366S in a cold environment may affect the VSD in S4 to perturb channel functions, potentially via the temperature-dependent hydrogen bond interactions between N1366 in D4/S1 and R1454 of D4/S4. Mutation of R1454 to the negatively charged residue aspartate (R1454D) or glutamate (R1454E) has been shown to slow the rate of fast inactivation (Mitrovic et al. 2000) . We found similar defects in the N1366S mutant channel at low temperature. S4-arginines are essential for the function of the NaV1.4 channel and their replacement removes a critical gating charge in S4, which has been shown to cause channel disorders (Cannon, 2010) . The missense mutations R1448C/H/L/P/S in the D4/S4 voltage sensor produce the same clinical phenotype of PMC (Chahine et al. 1994; Lerche et al. 1996; Bendahhou et al. 1999; Mohammadi et al. 2003; Dice et al. 2004) . These PMC mutations all present altered inactivation, as reported in electrophysiological studies of heterologously expressed channels. Together with the findings from the covalent modification of R1454 (Mitrovic et al. 2000) , it has been suggested that the D4/S4 domain is coupled to inactivation kinetics. By contrast, all the NaV1.4 mutations associated with hypokalemic periodic paralysis confer a gating pore that creates a leak pathway for ions, and are S4-arginine mutations in domains D1, D2 or D3, such as R222W (Park & Kim, 2010) , R666G (Sokolov et al. 2007; Struyk et al. 2008) , R669H (Struyk & Cannon, 2007) , R672S (Bendahhou et al. 2001) and R1135H (Matthews et al. 2009 ). These findings thus suggest that the roles of the four VSDs in NaV1.4 channels are not equivalent. Most of the PMC mutations, however, are located either on the 'fast-inactivation particle' (IFM) between domains D3 and D4, or the VSD of D4. Indeed, several mutations associated with PMC have been identified at the residues adjacent to N1366, such as M1360, I1363 and M1370 (Wagner et al. 1997; Okuda et al. 2001) .The functional role of this region in regard to coupling with PMC remains to be further clarified.
In conclusion, we identified a novel dominant N1366S mutation in the NaV1.4 α-subunit from a Chinese family affected by PMC and revealed cold-induced defects in channel activation and fast inactivation in this mutant using electrophysiological approaches. In addition, we discussed the structural-functional perturbations induced by the asparagine-to-serine substitution at 1366. Generally, our studies expand the mutation spectrum of SCN4A associated with PMC and provide insights into the structure, function and molecular pathophysiology of dysfunctional human NaV1.4 and other sodium channels.
